You are here: Policies > Bacterial vaginosis

Bacterial vaginosis (policy currently under review)

The UK NSC policy on Bacterial vaginosis screening in pregnancy



This policy is currently being reviewed as part of the UK NSC's regular review cycle of all policies.

The review process began in May 2012 and is estimated to be completed by Nov 2014.

Type Antenatal
Previous policy
Systematic population screening programme not recommended

Screening for this condition should not be offered.

Key downloads Last external review

What is screening?

Screening is a process of identifying apparently healthy people who may be at increased risk of a disease or condition. They can then be offered information, further tests and appropriate treatment to reduce their risk and/or any complications arising from the disease or condition. It is important to ensure that the benefits and downsides of screening have been properly thought through. The UK National Screening Committee (UK NSC) is responsible for reviewing screening policies every 3 years and making recommendations to ministers in the 4 UK countries about whether to not a screening programme for a certain condition should be set up.

» Find out more about screening, the role of the UK NSC or the policy review process

More about Bacterial vaginosis

Bacterial vaginosis is the most common cause of abnormal vaginal discharge in women of childbearing age. The condition occurs when there is a change in the natural bacterial balance in the vagina.

» Read more about bacterial vaginosis on NHS Choices

Policy stakeholders

British Association for Sexual Health and HIV
The Family Planning Association
Royal College of Obstetricians and Gynaecologists

The stakeholder groups will be involved when the policy is next reviewed. If you think your organisation should be added, please contact us. More about the policy review process, including the role of stakeholders, can be found in the guide to Engaging with the UK NSC's policy review process.

Related documents

icon Preterm birth evidence review - consultation version (PDF document, 1.38MB, 21/07/14)

More options

Go to top
page image